期刊文献+

司帕沙星在雏鸡体内药代动力学及残留的研究 被引量:4

Studies on Pharmacokinetics and Residues of Sparfloxacin in Chickens
在线阅读 下载PDF
导出
摘要 选用30日龄健康海兰鸡65只,按5mg/kg体重口服给予司帕沙星,定期采样,以高效液相色谱法测定血浆、肝、肾、心、肺和肌肉中司帕沙星的含量,研究司帕沙星在鸡体内的药动学与残留。结果表明:司帕沙星在血液中经时过程符合一级吸收二室开放模型,其主要动力学参数如下:t1/2α0.9585h,t1/2β11.7447h,tmax0,6514 h,Cmax0.5271 μg/ml,AUC1.7908mg/L/h。肾脏、心脏的药时数据符合一级吸收二项指数方程,其主要动力学参数分别为:t1/2Ka0.3733 h、0.1530h,t1/2k1.3007 h、2.1013h,tmax1.01420h、0.6239 h,Cmax2.1104μg/ml、1.6721 μg/ml,AUC6.51764 mg/L/h、6.2286mg/L/h。司帕沙星在肝脏、肺脏、肌肉中的经时过程符合一级吸收三项指数方程,主要动力学参数分别为t1/2α0.3672 h、0.6156 h、1.5835 h,t1/2β3.9998 h、15.0271 h、12.0103h,tmax0.7458 h、0.7322 h、1.3726 h,Cmax4.4709μg/ml、2.5267μg/ml、0.9760μg/ml,AUC20.893 mg/L/h,27.242 mg/L/h、9.7943mg/L/h。建议司帕沙星在鸡体内的休药期为7d。 65 of 30-day-old healthy chickens were selected to study pharmacokinetics and residues of Sparfloxacin by HPLC. The results obtained showed that the blood concentration-time curves after oral administration were best described by a two compartment open model. The main pharmacokinetic parameters were as follows: t1/2α0.958 5 h, t1/2β11.745 h, tmax0.651 4 h, Cmax0.527 1 μg/ml, AUC1.790 8 mg/L/h. The kidney and heart concentration-time curves fitted the biexponential equation with first order absorption. Their main pharmacokinetics parameters were t1/2Ka0.373 3 h, 0.153 0h; t1/2K1.300 7 h, 2.101 3 h; tmax1.042 0h, 0.623 9 h; Cmax2.110 4 μg/ml, 1.672 1 μg/ml; AUC6.576 4 mg/L/h, 6.228 6 mg/L/h. And the liver, lung and muscle concentration-time data were best described by a triexponential equation with the first order absorption. The main pharamacokinetics parameters were as follows: t1/2α0.367 2 h, 0.615 6 h, 1.583 5 h; t1/2β3.999 8 h, 15.027 1 h, 2.010 3 h; tmax0.745 8 h, 0.732 2 h, 1.372 6 h; Cmax4.470 9 μg/ml, 2.526 7 μg/ml, 0.976 0 μg/ml, AUC20.893 mg/L/h, 27.242 mg/L/h, 9.794 3 mg/L/h, respectively. The withdrawal time of Sparfloxacin in chickens were suggested as 7 days.
出处 《现代畜牧兽医》 2004年第11期37-39,共3页 Modern Journal of Animal Husbandry and Veterinary Medicine
关键词 司帕沙星 雏鸡 药代动力学 药物残留 Sparfloxacin chickens pharmacokinetics residues
  • 相关文献

参考文献4

  • 1Hakamura S, Minami A, Nakata K, et al. In vitro and in vivo antibacterial activities of AT-4140, a new broadspectrum quinolone [J]. Antimicrob Agents Chemother, 1989,33(8): 1167.
  • 2Hoogkamp Korstanje JA. In vitro activities of ciprofloxacin,levofloxacin, lomefloxacin, ofloxacin, pefioxacin, sparfloxacin and trovaflocacin against gram-positive and gram-negative pathogens from respiratory trac infections[J]. J Antimicrob Chemother, 1997,40(3) :427.
  • 3刘明春,佟恒敏,马兴元,赵玉军.司帕沙星体外抗菌活性的试验[J].中国兽医科技,2003,33(5):52-54. 被引量:2
  • 4许铁男.新喹诺酮类抗菌药司帕沙星的药代动力学[J].国外医药(抗生素分册),1996,17(3):220-223. 被引量:13

二级参考文献3

  • 1许铁男.长半衰期新喹诺酮类抗菌剂司帕沙星[J].国外医药:抗生素分册,1995,16(3):238-238.
  • 2甘肃农业大学.兽医微生物学实验指导[M].北京:农业出版社,1997..
  • 3吕增春,邢玉斌.喹诺酮类抗菌药的分类和进展[J].国外医药(抗生素分册),2001,22(2):73-76. 被引量:22

共引文献13

同被引文献12

  • 1夏文江 成章瑞.MCPKP-药物动力学室分析的一种微机程序[J].中国药理学报,1988,9:188-188.
  • 2HOOGKAMP KORSTANJE JA.In vitro activities of ciprofloxacin,levofloxacin,lomefloxacin,ofloxacin,pefloxacin,sparfloxacin and trovaflocacin against gram-positive and gram-negative pathogens from respiratory trac infections[J].J Antimicrob Chemother,1997,40(3):427.
  • 3HENRY D,ELLISON W,SULLIVAN J,et al.Treatment of community acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin[J].Antimicrob Agents Chemother,1998,42(9):2262.
  • 4ELLIE HERSHBERGER,ELIZABETH A C,GLENN W K,et al.Comparison of a rabbit Model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations[J].Antimicrobial Agents and Chemotherapy,2000,44(7):1921-1924.
  • 5CHARLOTTA EDLUND,CARL ERIK NORD.Effect of quinolones on intestinal ecology[J].Drugs,1999,58(Suppl.2):65-70.
  • 6Hoogkamp Korstanje J A.In vitro activities of ciprofloxacin,levofloxacin,lomefloxacin,ofloxacin,pefloxacin,sparfloxacin and trovaflocacin against gram-positive and gram-negative pathogens from respiratory trac infections[J].J Antimicrob Chemother,1997,40(3):427.
  • 7Ellie Hershberger,Elizabeth A C,Glenn W K,et al.Comparison of a rabbit model of bacterial endocarditis and an In vitro Infection model with simulated endocardial vegetations[J].Antimicrobial Agents and Chemotherapy,2000,44(7):1921-1924.
  • 8Brown S A, Chester S T, Robb E J, et al. Effect of age on the phar- macokinetics of single dose ceftiofur sodium administered intrave- nously to cattle [J]. J Vet Pharmacol Ther, 1996( 1 ) : 32-38.
  • 9Cer ,antes C C, B:'own M P, Gronwall R R, et al. Pharmacokinetics concentration of ceftiofur sodium in body fluids and endometrium af- ter repeated intramucular in mares [ J]. Am J Vet Res, 1993 (54) : 573 -575.
  • 10宋福杰,刘明春,符特.兽用抗菌药物结晶性头孢噻呋的研究进展[J].安徽农业科学,2008,36(8):3236-3236. 被引量:3

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部